Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magnetic ring for heartburn tracked for 10 years

NCT ID NCT04253392

Disease control Sponsor: Ethicon Endo-Surgery Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Aug 28, 2026 · Updated 4 times

Summary

This registry follows 500 adults who receive the LINX device, a ring of magnetic beads implanted around the esophagus to help keep stomach acid down. The goal is to check for safety issues like device movement, erosion, or swallowing problems over up to 10 years. Participants will also report how their reflux symptoms and quality of life change.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
LINX Reflux Management System (magnetic bead ring implanted around the esophagus)
What this could lead to
If successful, this registry will confirm that the LINX device is safe and effective for controlling GERD over the long term, helping patients avoid daily medication.
What could go wrong
This is an observational registry, not a controlled trial, so it cannot prove the device works better than other treatments. Risks include device erosion, migration, or need for removal.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

500 people

The number who actually took part.

Started

Jul 2020

Expected to finish

Jul 2032

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adult patients successfully implanted (treated) with the LINX Reflux Management System for the treatment of GERD (Implant success defined as leaving the surgical suite with a device in situ)

Ages

21 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Subject is \>or=21 years old 2. Subject with prospective plans for a LINX procedure 3. Subject provides written informed consent 4. Subject must be willing and able to complete questionnaires/ surveys electronically (ePROs) Exclusion Criteria: 1. Subject who was previously implanted with LINX device 2. Any reason which the Principal Investigator believes may cause the subject to be non-compliant with or unable to meet the protocol requirements (i.e. medical illness and/or limited life expectancy of less than 10 years) Note: Physicians should refer to the LINX Reflux Management System IFU for a complete list of contraindications, warnings, and precautions.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Gastroesophageal reflux are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

esophageal disorder gastroesophageal reflux disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Gastroesophageal reflux

Contacts and locations

Locations

  • Adv Surg Assoc / Self Regional Healthcare

    Greenwood, South Carolina, 29646, United States

  • Bariatric Medical Institute of Texas

    San Antonio, Texas, 78258, United States

  • East Carolina University / Vidant Medical Center

    Greenville, North Carolina, 27834, United States

  • Epsom Hospital

    Epsom, KT18 7EG, United Kingdom

  • Fox Valley Surgical Associates

    Appleton, Wisconsin, 54911, United States

  • Gen Surg Assoc / Fairfield Medical Center

    Lancaster, Ohio, 43130, United States

  • Guy's and St. Thomas' Hospitals

    London, SE1 7EH, United Kingdom

  • Houston Methodist

    Houston, Texas, 77030, United States

  • Institute of Esophageal and Reflux Surgery

    Englewood, Colorado, 80113, United States

  • Keck Hospital of USC

    Los Angeles, California, 90033, United States

  • Lehigh Valley Hospital - Cedar Crest

    Allentown, Pennsylvania, 18102, United States

  • Lexington Surgery

    West Columbia, South Carolina, 29169, United States

  • Marien Hospital Herne

    Herne, 44625, Germany

  • MedUni Wien / Universitatsklinik fur Chirurgie

    Vienna, 1090, Austria

  • Minimal Access Surgery/Prisma Health - Upstate

    Greenville, South Carolina, 29607, United States

  • NW Allied Bariatric and Foregut Surgery

    Tucson, Arizona, 85741, United States

  • National University Hospital

    Singapore, 119228, Singapore

  • OSF Medical Group

    Peoria, Illinois, 61615, United States

  • Panhandle Weight Loss Center

    Amarillo, Texas, 79106, United States

  • RefluxUK

    Royal Tunbridge Wells, TN3 0RD, United Kingdom

  • Richmond Surg / Henrico Doctors' Hospital

    Richmond, Virginia, 23229, United States

  • Saint Elizabeth Healthcare Edgewood

    Edgewood, Kentucky, 41017, United States

  • Sparrow Hospital / Sparrow Medical Group

    Lansing, Michigan, 48912, United States

  • Swedish Medical Center

    Seattle, Washington, 98104, United States

  • The Ohio State University

    Columbus, Ohio, 43210, United States

  • Univ of Milano / IRCCS Policlinico San Donato

    San Donato Milanese, 20097, Italy

  • University of South Alabama

    Mobile, Alabama, 36617, United States

  • University of Southern Florida (Tampa General Hospital)

    Tampa, Florida, 33606, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.